Avalon Globocare Corp (OTCMKTS:AVCO) Director Wenzhao Lu purchased 21,000 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was acquired at an average price of $2.03 per share, with a total value of $42,630.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.
OTCMKTS:AVCO opened at $2.60 on Friday. Avalon Globocare Corp has a 52 week low of $1.77 and a 52 week high of $13.50. The business’s 50-day simple moving average is $2.27.
Avalon Globocare (OTCMKTS:AVCO) last announced its quarterly earnings results on Tuesday, May 14th. The company reported ($0.06) earnings per share (EPS) for the quarter. Avalon Globocare had a negative net margin of 365.09% and a negative return on equity of 81.16%. The company had revenue of $0.28 million for the quarter.
Avalon Globocare Company Profile
Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology, as well as rehabilitation medicine.
Further Reading: Dividend Achievers
Receive News & Ratings for Avalon Globocare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon Globocare and related companies with MarketBeat.com's FREE daily email newsletter.